Skip to content

A study to test the effectiveness of the test product in reducing age related signs like dark spots and fine lines.

Anti-Aging Efficacy of the test product in improving skin biophysical properties a clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097635
Enrollment
40
Registered
2025-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Cosmetic product SA22: Participants will be asked to apply the product twice daily for 8 weeks Control Intervention1: Nil: N/A

Sponsors

Hindustan Unilever Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female adult trial participants in general good health as determined from a recent medical history and dermatological examination. 2. Trial participants in the age group of 40-60 years 3. Trial participants showing signs of aging on skin like fine line, crow feet 4. Trial participants with dark spots 5. Trial Participants agreeing to adhere to study protocol requirements and restrictions

Exclusion criteria

Exclusion criteria: 1. Trial participant who are pregnant, lactating or nursing (self-declared) 2. Trial participants who have used any skincare products in last one month before this study. 3. Trial participants who have participated in any clinical study involving facial test sites within the past 6 months 4. Trial participants with current or past history of any dermatological condition on the face 5. Trial participants currently taking any medication. 6. Trial participants who have any visible cuts, abrasions, or open wounds on the treatment area 7. Participants on any food supplements for skin or hair benefits or others.

Design outcomes

Primary

MeasureTime frame
Improvement in Texture, Hydration, Barrier strengthTimepoint: Baseline, Week 4 and Week 8

Secondary

MeasureTime frame
Safety assessments like redness and drynessTimepoint: Baseline, Week 4 and Week 8

Countries

India

Contacts

Public ContactSudhanthiran S

MS Clinical Research Pvt. Ltd

ritambhara@msclinical.com08040917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026